Visual Recognition of Paper Analytical Device Images for Detection of
  Falsified Pharmaceuticals by Banerjee, Sandipan et al.
Visual Recognition of Paper Analytical Device Images for Detection of Falsified
Pharmaceuticals
Sandipan Banerjee1, James Sweet1, Christopher Sweet1, and Marya Lieberman2
1Department of Computer Science and Engineering,
2Department of Chemistry and Biochemistry,
University of Notre Dame
{sbanerj1, jsweet, csweet1, mlieberm}@nd.edu
Abstract
Falsification of medicines is a big problem in many de-
veloping countries, where technological infrastructure is in-
adequate to detect these harmful products. We have devel-
oped a set of inexpensive paper cards, called Paper Ana-
lytical Devices (PADs), which can efficiently classify drugs
based on their chemical composition, as a potential solu-
tion to the problem. These cards have different reagents em-
bedded in them which produce a set of distinctive color de-
scriptors upon reacting with the chemical compounds that
constitute pharmaceutical dosage forms. If a falsified ver-
sion of the medicine lacks the active ingredient or includes
substitute fillers, the difference in color is perceivable by
humans. However, reading the cards with accuracy takes
training and practice, which may hamper their scaling and
implementation in low resource settings. To deal with this,
we have developed an automatic visual recognition system
to read the results from the PAD images. At first, the optimal
set of reagents was found by running singular value decom-
position on the intensity values of the color tones in the card
images. A dataset of cards embedded with these reagents is
produced to generate the most distinctive results for a set of
26 different active pharmaceutical ingredients (APIs) and
excipients. Then, we train two popular convolutional neu-
ral network (CNN) models, with the card images. We also
extract some “hand-crafted” features from the images and
train a nearest neighbor classifier and a non-linear support
vector machine with them. On testing, higher-level features
performed much better in accurately classifying the PAD
images, with the CNN models reaching the highest average
accuracy of over 94%.
1. Introduction
Billions of people in developing countries are facing the
problem of fake or substandard pharmaceuticals. Poor qual-
Figure 1: (a) Unrectified PAD image of the drug acetaminophen with
different reagents in the 12 different vertical lanes, (b) PAD image
artwork.
ity medications may contain harmful or inert ingredients
that fail to treat the patient’s underlying condition. Drugs
which contain sub-therapeutic levels of an active ingredi-
ent contribute to development of drug-resistant pathogens.
The human toll of these products is large. Falsified anti-
malarials have been estimated to kill 120,000 children un-
der the age of 5 each year [1]. Although there are phar-
macopeia methods for analysis of medications, they often
cannot be applied in the developing world due to lack of
technical and regulatory resources, and studies consistently
show that 15 - 30% of medications for sale in Africa, south-
east Asia, and other low resource settings are substandard
or fake. To address this problem Weaver et al. proposed the
idea of using inexpensive (under $1) paper analytical de-
vices (PADs) that contain libraries of color tests to respond
to the chemicals inside a pill [3]. The PADs have 12 vertical
“lanes” in which chemical reagents are embedded. When a
drug is swiped across these lanes and the PAD is dipped
in water, the reagents react with the different compounds in
the drug, generating characteristic color tones in the vertical
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Figure 2: PAD images with fake and authentic versions of the drug
coartem.
lanes, usually at or above the drug swipe (see Figure 1.a).
The distinctive set of color tones generated for a particular
drug acts like its “fingerprint”, and is considerably different
from that of a counterfeit version of the same drug (Figure
2).
The different steps of the color testing process of a PAD
has been illustrated in Figure 3. At present, the user evalu-
ates the results of the test by visually comparing their PAD
to stored images of cards run with standard pharmaceutical
samples. However, reading the card results is much more
challenging than actually running the chemical tests with
them. Important differences in the color tones are not al-
ways picked up by human users, and the time and effort
required to train people to read the cards correctly and ver-
ify their capability is a barrier to wider scaling of the use of
the cards. To tackle this, we have developed a visual recog-
nition system which can classify a PAD image based on the
pharmaceutical drug being tested. Only 18% of people in
Africa had access to the internet in 2013 although two out of
three used a mobile phone [2], we thus decided that the im-
age recognition system should be compatible with the cell
phone network. The user should be able to submit a PAD
image through her cell phone and the system should return
a quality score of the tested drug back to the user. By using
messaging services instead of the internet to transfer card
images and the results, this system is designed to be usable
by people who live in developing countries. In this paper,
we discuss the different steps of the visual recognition pro-
cess of the PAD images. Different feature extraction meth-
ods and their performance in recognizing the drugs using
different classifiers are also presented.
The remainder of this paper is structured as follows.
Prior research relevant to this problem, and how our work
is different from them, is discussed in section 2. In sec-
tion 3 we describe the images we prepared for this work
Figure 3: The different phases of the color testing process of a PAD.
and the methods used to decide on a design choice for the
PAD cards. Section 4 explains the different feature extrac-
tion methods and the classifiers used for the experiments.
The experimental results are discussed and further analyzed
in section 5. Section 6 concludes the paper.
2. Related work
Modern medicine has reached great heights in the last
one or two decades and it has brought about a huge growth
of pharmaceuticals in the market. However, the police, reg-
ulators, healthcare providers, and patients are often faced
with the task of identifying a mystery pill or tablet. Much
of the work that has been done on automatic drug identi-
fication is from the last decade. Most of the researchers
have discussed automatic pill recognition protocols based
on the color, shape and imprint information on the pills in
[4, 5, 6]. The work of Lee et al. in [7] is worth mentioning
in this regard, where they try to retrieve images of similar
pills when provided with a query pill image. They extract
the color histogram and the Hu moments [24] based on the
shape of the pill as features. Additionally, SIFT [25] and
MLBP [26] descriptors are used to encode any imprint in-
formation present on the pills. The matching accuracy for
these pills is computed using both individual features and
their different combinations. They report a rank-1 retrieval
accuracy of about 73%. Such pill identification systems,
such as [8, 9, 10], are available online for general purpose
use.
Our work is considerably different from what has been
proposed in these papers as we crush the pills and swipe
them on the PAD cards for classification based on their
chemical composition. Thus, instead of identifying the pill
based on its appearance we recognize the drug based on its
chemical composition, which is revealed by the chemical
“fingerprint” it makes in reacting with the reagents embed-
ded in the PAD cards. The main objective of our work is to
detect pills whose formulations do not match the authentic
version. Fake pills can match the real ones exactly in ap-
pearance, but if the ingredients of the pill are different, the
color fingerprint generated on the PAD will be considerably
different from that of the real drug. An additional advantage
of the PAD method is that some types of falsification can be
detected even if an authentic sample of the particular brand
of pill is not available. To our knowledge, there is no pub-
lished work in the literature which uses vision techniques
for the recognition of the PADs and our work is the first of
its kind.
3. Preparation of the PAD cards and their im-
ages
For correct identification of different pharmaceuticals
using the PAD images, the cards have to be first prepared
with the best set of up to 12 reagents (one for each lane)
which produces the most unique color tones for the different
drugs. For our experiments, 26 pharmaceutical drug sam-
ples1 were chosen either because they have been reported
in the literature as ingredients in falsified formulations (e.g.
corn starch, acetaminophen) or because they are in the list
of WHO essential medicines [11], with high sales volume in
the developing world (e.g. amoxicillin, isoniazid). For this
26 drug samples, we choose the best 12 from a set of 24
reagents. In order to analyze the card images, the raw un-
aligned image taken with a cell phone needs to be rectified
and properly aligned prior to the feature extraction process.
Therefore, the card preparation and image rectification are
two key steps in proper drug classification. We describe the
PAD image alignment process first, and then the optimal
reagent selection process below.
3.1. PAD image rectification
The PAD cards are photographed after the reactions be-
tween the drug and each reagent have taken place. How-
ever, the lanes in the resulting image are unaligned and
don’t match the locations of the original PAD artwork (Fig-
ure 1.b). So, some transformation is required before the
analysis can proceed. The images have varying resolution,
scaling, rotation, offsets and perspective attributes to cor-
rect for. The method we use to accomplish this is described
below.
The PAD card is pre-printed with a QR code in the up-
per left hand corner (containing the image metadata) and
three additional fiducial marks at the remaining corners.
The PAD processing software uses a variant on the QR
1The drugs are: acetaminophen, acetylsalicylic acid, amodiaquine,
amoxicillin, ampicillin, artesunate, azithromycin, calcium carbonate,
chloramphenicol, chloroquine, ciprofloxacin, corn starch, DI water, di-
ethylcarbamazine, dried wheat starch, ethambutol, isoniazid, penicillin G,
potato starch, primaquine, quinine, rifampicin, streptomycin, sulfadoxine,
talc and tetracycline.
Figure 4: (a) The rectified version of the PAD image from Figure 1, (b)
the cropped out salient region from the rectified PAD image.
code alignment marker finding algorithm to locate the fidu-
cial marks, together with the QR code markers, to acquire
a maximum of six reference points. The resulting points
are processed with the popular OpenCV [12] library to do a
offset, scaling, rotation and perspective correction to match
the coordinates of the artwork. In addition to the ink print
layer, the face of the card is printed with wax lines that are
baked into the paper to separate the reagent lanes. Since the
lanes can be misaligned with the original ink layer due to the
printing process, two wax fiducial markers are added and a
template matching scheme within OpenCV is used to find
their coordinates. These coordinates are used to remove the
offset and rotation of the lanes within the rectified version
of the PAD image, example shown in Figure 4.a (730x1220
in size).
3.2. Selection of the optimal set of reagents
24 different reagents were tested to determine which
ones produced the most useful color outcomes for classi-
fication of the 26 pharmaceuticals and fillers tested in this
study. We prepared a set of cards in which 9 of the 12
lanes contained a given reagent; the lanes were arranged in
groups of three with a spacer between each group (Figure
5). One of 26 pharmaceuticals or fillers was swiped across
these lanes to give groups of light, medium and heavy con-
centrations of the analyte.
The cards were activated by dipping the bottom edge in
water, as shown in Figure 3. The different reagent/analyte
combinations produce a variety of colors, and often a single
lane gives multiple colors in different locations, which can
be difficult for a human to interpret. Because the chem-
ical reactions are designed to generate strong colors, we
consider the color “blobs” having the color intensity far-
thest from white (the background card color) to be the most
Figure 5: (a) Rectified PAD image of the drug acetaminophen with the
reagent that detects phenol groups in the 9 lanes from A - K, (b) rectified
PAD image of acetaminophen with the reagent that detects beta lactam
groups in the 9 lanes from A-K. The drug concentration increases from
the left to the right of image, the pink hue in lane L is from the timer
agent.
Figure 6: (a) The overlapping blob contours generated by the region
growing algorithm in each lane, (b) the estimated actual reaction blob
contour in each lane.
meaningful color result of that lane (the reaction blob). In
order to locate it on the image, we first divide the lane space
above the swipe line into five equal regions. Then we run a
region growing algorithm from the centroid of each region,
and compute the 5 connected components from them. Since
the regions are close to each other and there are at most 1 or
2 residual blobs, multiple connected components are from
the same blob and they overlap, as can be seen in Figure 6.a.
We merge two such regions together if the number of
overlapping common pixels between the regions is greater
than a threshold. Experiments have shown the overlapping
regions to merge best when this threshold is set as 0.35
times the size (# of pixels) of the bigger region of the two.
Once this is done, we end up with 2 or 3 blobs in total per
lane, one of which is the actual reaction blob and the others
are residual. Since the residual blobs are generally fainter
in color intensity than the reaction blob, we compute the
maximum difference across the R, G and B channels of the
mean pixel intensity for each blob as shown in equation (1).
We keep the blob with the highest value of maxDiff per lane
as it is the farthest from the background card color (white),
as shown in Figure 6.b.
maxDiff = max(| Rmean −Gmean |, | Gmean −Bmean |,
| Bmean −Rmean |)
(1)
9 reaction blobs are obtained in this way in the 9 lanes of
the PAD image. The mean RGB intensity of these 9 blobs
serve as a reaction color descriptor for a particular drug and
a reagent. A database of such descriptors is built for all the
possible pairs from the 26 drugs and 24 reagents. We inves-
tigate the uniqueness of each point in the database for a par-
ticular drug using the singular value decomposition (SVD)
method. A 26x24 matrix (M) is built which contains the Eu-
clidean distance of the mean RGB intensities between the
drug and each reagent. Decomposing M by applying SVD,
shown in equation (2), we obtain the singular matrices U
and V, and the diagonal matrix S.
M = USV t (2)
V is a 24x24 matrix which contains information about
the contribution of each reagent to the singular values of
M. Sorting the columns of V in a descending order of cor-
responding singular value lists the indices of the reagents
by their uniqueness for the particular test drug. They can be
termed as the optimal reagents for that drug. We capture the
first index from the sorted list, i.e. the index of the reagent
that produces the most distinctive reaction color with that
drug, for all the 26 drug samples in a list. The list contains
9 different reagents, as many reagents react very distinc-
tively with multiple drugs. Based on this list, we compute
the norm between all drug sample pairs from information in
matrix M to verify the uniqueness of the results. All sam-
ples are found to have an inter-class norm of more than at
least 1 intra-class standard deviation of that drug. We added
2 more reagents which are known to produce unique results
from their chemistry to the list2. We then prepared new 12-
lane cards with a timer lane and the 11 optimal reagents,
as shown in Figure 1.a, and used these cards to generate
color fingerprints from the 26 active pharmaceutical ingre-
dients and excipients. The colors from the chemical reac-
tions between the drug and the reagents are formed either at
or above the swipe line, so we crop out these salient regions
from the rectified PAD images (resolution of 636x490), and
2Optimal reagents (lane A to lane L): Ni/nioxime timer, ninhydrin
test for primary amines, biuret reagent, acidic cobalt thiocyanate, neu-
tral cobalt thiocyanate, copper test for beta lactam, sodium nitroprusside,
napthaquinone sulfonate, copper test for ethylenediamines, iodine test for
starch, phenol test and ferric ion.
Figure 7: The visual representation of the filter and their responses from
the 1st, 2nd and 3rd convolutional layers (conv1, conv2 and conv3
respectively) in Caffenet.
store them in the database, discarding the rest of each image
(Figure 4.b).
4. Feature extraction and classification
Since the PAD images are not just a set of color tones
but also contain characteristic blob patterns, we explored a
broad set of features, ranging from low-level to high-level.
Each feature used in our experiments and the classifiers
used for it are described below.
L*a*b* color histogram: The primary distinguishing
factor for classifying two PAD images of two different
drugs is by comparing their color fingerprints. Some of the
images have reaction blobs restricted to a certain number of
distinguishable colors while others span across a wide va-
riety of color tones. We capture a 90-dimensional binning
of the L*a*b* histogram as a feature that characterizes the
color distribution in the images.
GIST descriptors: We use the GIST descriptors (512
dimensions) as another low-level feature as it describes the
spatial envelope of the image and provides a good represen-
tation of the visual field [23].
Color bank: This is the color bank feature proposed in
[17]. The PAD image is first converted to a set of color
names [18, 19] and the histogram of these names is ex-
tracted from dense overlapping patches of different sizes
from the images. We learn a dictionary (of size 20) using k-
means [20] from a random sampling of the patch histograms
and apply locality-constrained linear coding (LLC) [21] to
soft-encode each patch to dictionary entries. Then, max
pooling is applied with a spatial pyramid [22] on the dic-
tionary to obtain the final feature vector (420 dimensions).
Dense SIFT: The SIFT descriptor [25] captures the lo-
cal patterns in the image in a scale and orientation invariant
manner. We extract the SIFT descriptors from a dense grid
over the images at different patch sizes. A dictionary is ob-
tained by applying k-means (k = 256) on these descriptors
and we soft encode the dictionary entries with LLC. Then
the final feature vector (5376 dimensions) is obtained by
applying max pooling with a spatial pyramid on the dictio-
nary.
Convolutional neural network: The recent resurgence
of deep learning models and their high performance in vi-
sual recognition tasks shows a lot of promise in this regard.
Instead of hand-designed features traditionally used for vi-
sual recognition, the convolutional neural network (CNN)
models extract features automatically in their intermediate
layers from the input images while training the network.
The fact that CNN based models have been winning the last
few editions of the ImageNet Large Scale Visual Recogni-
tion Challenge (ILSVRC) [13], which deals with recogniz-
ing objects from a million images, underpins its robustness
and the reliability of its automatic feature design process.
We use Caffe [16] for feature extraction, training and testing
two popular model architectures with our data, as described
below.
• Caffenet: It is a clone of the network (5 convolutional
+ 3 pooling layers) which won the ILSVRC 2012 con-
test proposed by Krizhevsky et al. in [14] for general
object recognition. We use only the architecture as it
is, except in the last fully connected layer where the
number of output is changed to 26, and train the net-
work with our PAD image data from scratch. The fea-
tures, both low and high level, are automatically cap-
tured by the network in the filter maps of its interme-
diate layers, as shown in Figure 7.
• GoogLeNet: It is the ILSVRC 2014 winning “very
deep” 22-layer network architecture from Google, de-
scribed in [15]. We use the architecture only, with the
configuration of the fully connected layers changed,
and train it with the PAD images from scratch. The
features are captured in the intermediate layer filters.
To train and test the features discussed above, except
those from the CNN models, we use two classifiers: a
simple squared-Euclidean distance based nearest neighbor
(kNN, where k = 1) and a multi-class support vector ma-
chine (SVM) with a radial basis kernel. The SVM train-
ing parameters are estimated using cross-validation on the
dataset. We chose the softmax regression layer used for
classification in the original networks described above, for
training and testing with the CNN features. Thus, we use
the entire pipeline of these models for both feature extrac-
tion and classification of the PAD images.
5. Experiments and results
For our experiments we prepare a dataset of 30 images
(cropped salient regions) per drug, making a total of 780
images for the 26 drugs. We randomly select 20 images for
training for each drug and use the remaining 10 for testing,
giving us a total of 520 images for training and 260 for test-
ing. The classifiers (kNN and SVM) are trained using the
features described in the previous section. The CNN models
Table 1: Average classification accuracy of PAD images
Method Accuracy (%)
L*a*b* histogram with kNN 138/260 (53.07%)
L*a*b* histogram with SVM 172/260 (66.15%)
GIST with kNN 216/260 (83.07%)
GIST with SVM 230/260 (88.46%)
Color bank with kNN 235/260 (90.38%)
Color bank with SVM 231/260 (88.84%)
Dense SIFT with kNN 200/260 (76.92%)
Dense SIFT with SVM 233/260 (89.61%)
Color bank + dense SIFT with kNN 238/260 (91.53%)
Color bank + dense SIFT with SVM 240/260 (92.30%)
Caffenet 245/260 (94.23%)
GoogLeNet 243/260 (93.46%)
train with the features they capture from the images auto-
matically. We set a maximum cap of 100,000 iterations for
training for both the models as our dataset is much smaller
compared to ImageNet [27]. The network models tend to
converge earlier than that, generally between the 70,000 -
80,000 iterations. The weight configuration (model state)
which gives the best performance on the validation images
is selected for testing. Since our data set is small in size,
to handle overfitting (especially for the CNN models) on
the training data, we perform training from scratch using
a 3-fold cross validation approach on the available dataset
and calculate the classification accuracy by averaging re-
sults from each experiment. The top-1 accuracy, averaged
over the 3 folds, of each method in correctly classifying the
test PAD images can be seen in Table 1.
Clearly, some methods are better than others in classi-
fying the cards. For example, with the color histogram
alone as the feature almost half the test images are misclas-
sified while the predictions are much more accurate when
using higher level features. However, no one method can be
marked as the outright winner in a statistical sense, as their
confidence intervals overlap over the 3 folds. Interestingly,
both the CNN models do a good job in classifying the PAD
images, with Caffenet churning out the most accurate aver-
age predictions for our dataset. The average confidence for
each drug class that Caffenet makes a prediction for can also
be found in Figure 8. Although the data is limited, still the
network is quite precise in making the accurate predictions
in majority of the cases considering that chance prediction
confidence is 0.038 (1/26). Caffenet slightly outperform-
ing (less than 1%) GoogLeNet is suggestive of the fact that
deeper features of the latter don’t contain any additional in-
formation for our small and well structured dataset. We
anticipate GoogLeNet to outperform Caffenet on a larger
dataset of PAD images which have higher variance in them.
The CNN model architectures we used are originally de-
Table 2: Average classification accuracy of non-structured PAD images
with Caffenet
Method Accuracy (%)
Unrectified images with Caffenet 233/260 (89.61%)
Images with random lane order with Caffenet 87/260 (33.46%)
signed for general object recognition, training with thou-
sands of images for feature extraction. However, the im-
ages that are used for training have a high level of variance,
both intra-class and inter-class. Our dataset, although much
smaller in size, has images which are not so random and
much more structured. That might be the reason behind the
feature learning mechanisms of these architectures transfer-
ring well to a specific recognition task like ours. To explore
this further we decided to run some additional experiments
on Caffenet.
We predicted two factors to be contributing to this high
performance on Caffenet - (1) the rectification and salient
region cropping process of the raw PAD images as de-
scribed in section 3 and (2) the rigid ordering of the reagents
in the lanes. To check the influence of the rectification pro-
cess on the performance, we built a dataset with unrecti-
fied wild type images for the same 26 drugs and optimal
reagents. An example image can be seen in Figure 9.a. The
images are directly used for training and testing, without
any cropping of the salient region as well. We train Caf-
fenet with 520 images as before and test with the remaining
260. The result can be found in Table 2. Although the ac-
curacy in this case drops a little, it still does a better job
in classifying the drugs than some of the other methods do
with even rectified images. The filter maps, when pulled
out from the network, suggest that the network locates the
salient regions automatically even from the unrectified im-
ages (Figure 9.b).
To examine the effect of the rigid ordering of the reagents
in the vertical lanes has on the classification performance,
we perturb the structure of the PAD images again. We ran-
domly re-order the lane positions in the training and test-
ing salient crops for each drug such that the position of a
reagent (lane A - lane L) in the training images is differ-
ent than its position in the test images. A pair of example
training and testing images can be seen in Figure 10. We
train Caffenet as before, with 520 perturbed images and test
it with 260 images. The accuracy goes down significantly
in this case, as shown in Table 2. The result clearly indi-
cates that the reordering of the reagents hampers Caffenet’s
learning process as the features captured during training are
much different from the test features. Thus, the network in-
deed looks at blob patterns in the images and not just the
color tones when extracting features.
Figure 8: The average prediction confidence for classifying each drug class in Caffenet. The diagonal values represent the prediction confidence for that
drug index.
Figure 9: (a) A sample unrectified wild type PAD image for the drug
rifampicin, (b) the filter response generated for unrectified card by the 2nd
convolutional layer (conv2) in Caffenet.
6. Conclusion
In this paper, we have proposed the novel problem of vi-
sual classification of pharmaceutical drugs and its applica-
tion in counterfeit drug detection. Unlike prior research in
this area, our work doesn’t use the shape, color or imprint
information or the pill appearance itself for this purpose.
Instead we focus on the chemical composition of the drug
by observing the color tones it generates reacting with dif-
ferent reagents on a PAD card, like a chemical fingerprint
of the drug. This facilitates the detection of fake drugs, as
the change in chemical composition can easily be picked up
by the chemical tests. We developed a dataset of 780 PAD
Figure 10: (a) A perturbed training image for the drug acetaminophen, (b)
a perturbed testing image for the same drug. It can be easily observed that
the lane positions are different for the two images.
cards with 26 drugs and 11 optimal reagents (and a timer
agent) to conduct our experiments. The raw PAD images
were aligned using a rectification process and the salient re-
gion from each image was cropped out. We extracted hand-
crafted features from the salient crops and trained kNN and
SVM classifiers with them. We also trained two popular
CNN architectures (Caffenet and GoogLeNet), originally
designed for general object recognition, with these images.
Both the models performed well in accurately classifying
the test card images with Caffenet giving the highest aver-
age accuracy of over 94% on our dataset. On experimenting
with unrectified and unstructured PAD images on Caffenet
it was observed that the order of the different reagents in
the vertical lanes of the cards is a vital factor in accurate
classification of the drugs.
While our research has made a promising start, more
work is needed in certain areas. To improve the classifi-
cation performance we require more data i.e. more physical
cards to take the images from. Our collaborators in Africa
have been sending in their test images (actual field data) re-
cently and we are in the process of making a bigger database
for classification with more drugs. The other option is to au-
tomate the card preparation process. Currently we manually
bake, embed reagents, swipe drug and test the cards by hand
in a wet lab, which is both time-consuming and tedious.
We plan to automate this so that the cards are manufactured
faster and in a more streamlined manner. The other possi-
ble extension of our work would be to design our own CNN
architecture, instead of using one out of the box. Although
Caffenet performs well in classifying the PAD images, still
its originally designed for general object recognition. A net-
work designed for a more specific object classification, like
ours, should improve the performance. Lastly, we are in
the process of implementing a message service based cell
phone application through which any person in possession
of a PAD card would be able to send us their test images.
This will be the best way to get our hands on large quanti-
ties of images, including different brands of pharmaceutical
products and falsified drugs, to improve the visual recog-
nition system. If just one sample of a very poor quality
medication is found using the system, additional targeted
sampling, analysis, and regulatory action can be carried out
to get the affected products off the market.
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